The ability of IL-37 to suppress the inflammatory activities in AVICs induced by endogenous stimulants underscores its potential for suppression of valvular inflammation and for prevention of CAVD progression. The gene discussed is IL37; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.